-
Use of EORTC Item Lists for Patient-Reported Outcome Measurement in Industry-Sponsored Research: A Three-Year Snapshot of Study Characteristics
Sep 9, 2025, 16:22 PM -
Evaluation of Health-Related Quality of Life (HRQoL) Among Patients Treated With Lifileucel After Progression on Immune Checkpoint Inhibitors (ICIs) and Targeted Therapies: Analyses From the C-144-01 Trial
Sep 9, 2025, 16:22 PM -
Work Complexity in Adults With Phenylketonuria in Sweden in 2020
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization in Adults with Type 1 Diabetes Who Have a Prior Type 2 Diabetes Misdiagnosis and Recorded HbA1c in a US Managed Care Population
Sep 9, 2025, 16:22 PM -
Economic Model of Alzheimer's Disease That Incorporates the Uncertainty Associated With Measuring Efficacy in Clinical Trials
Sep 9, 2025, 16:22 PM -
Decoding Atorvastatin-Induced Arthritis: A Systems Pharmacology Approach Integrating Pharmacovigilance, Bioinformatics, and Pathway Enrichment
Sep 9, 2025, 16:22 PM -
Quantifying the Economic Impact of Flexible Endoscope-Related Procedure Rescheduling in NHS Endoscopy Services: A Retrospective Analysis and Survey-Based Model
Sep 9, 2025, 16:22 PM -
The Epidemiology Burden and Management of Chronic Hand Eczema in Adolescents: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Tropical Virus in France: Dengue Cases on the Rise
Sep 9, 2025, 16:22 PM -
MIRROR KEYNOTE: Generating Real-World External Control Arms in Non-Small Cell Lung Cancer Using a Curated Database
Sep 9, 2025, 16:22 PM -
Gaps in Cancer Screening Uptake in Ireland: Trends, Barriers and Policy Implications
Sep 9, 2025, 16:22 PM -
Institutional Trends and Healthcare Resource Utilization in Real-World NMIBC and MIBC Treatment in Germany
Sep 9, 2025, 16:22 PM -
Measurement of Functional Outcome Using the Modified Rankin Scale in Patients With Acute Ischemic Stroke
Sep 9, 2025, 16:22 PM -
Factors Associated With Positive Cost-Effectiveness Judgments in HIRA Drug Reimbursement Decisions: An 8-year Retrospective Review
Sep 9, 2025, 16:22 PM -
Comparing Clinical Benefit Criteria in Health Technology Assessment of Oncology Drugs in the Netherlands and Europe: Driving Real Value or Inequal Access?
Sep 9, 2025, 16:22 PM -
External Reference Pricing (ERP) Availability vs. Reimbursement Timelines in Poland and Other European Countries: The Analysis of EURIPID Database
Sep 9, 2025, 16:22 PM -
Five-Year Clinical and Economic Impact of 20 Weight Loss in Adults With Obesity in Saudi Arabia: A Public Healthcare Perspective
Sep 9, 2025, 16:22 PM -
A Systematic Literature Review of Economic Evaluation Studies for Schizophrenia
Sep 9, 2025, 16:22 PM -
What Makes a Medicine Innovative? A Literature Review of Evaluation Frameworks
Sep 9, 2025, 16:22 PM -
Scaling Responsible Healthcare Data Access With AI-Driven Sensitive Patient Variable Detection
Sep 9, 2025, 16:22 PM
